Reuters logo
BRIEF-Sinovac reports 71.4 pct rise in Q3 revenue
2016年11月28日 / 上午11点17分 / 1 年前

BRIEF-Sinovac reports 71.4 pct rise in Q3 revenue

Nov 28 (Reuters) - Sinovac Biotech Ltd -

* Sinovac reports unaudited third quarter 2016 financial results

* Q3 non-gaap earnings per share $0.06 from continuing operations

* Q3 sales $28.7 million versus $16.8 million

* Quarterly net income attributable to common shareholders was $3.2 million, or $0.06 per basic and diluted share

* Says Q3 revenue increased 71.4% to $28.7 million from $16.8 million from same period of 2015

* Phase II clinical trial of SIPV is expected to be completed in Q3 of 2017 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below